Evidence map›Paper›PMID 20798932›Full record

ArticleAnalytical and bioanalytical chemistry2010

Silver nanoparticle-enhanced fluorescence in microtransponder-based immuno- and DNA hybridization assays.

Ji Li, Zhuying Wang, Ignacy Gryczynski, Wlodek Mandecki

Abstract read
In one paragraph

Article in Analytical and bioanalytical chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ji LiPharmaSeq, Inc, 11 Deer Park Dr., Suite 104, Monmouth Junction, NJ 08852, USA.
Zhuying Wang
Ignacy Gryczynski
Wlodek Mandecki

Funding

Use of silver nanostructures on microtransponders in ultra-sensitive assayR44CA132547 · NCI · PHARMASEQ, INC. · PI MANDECKI, WLODEK · 2010 to 2011
$1.3M
Use of Silver Nanostructures on Microtransponders in Ultra-sensitive AssayR43CA132547 · NCI · PHARMASEQ, INC. · PI MANDECKI, WLODEK · 2008 to 2009
$298k
NCI NIH HHS CA132547NCI NIH HHS R43 CA132547NCI NIH HHS R44 CA132547
6 · The paper itself

Abstract

The aim of this study is to improve assay sensitivity in common solid-phase bioassay configurations as the result of using silver nanoparticles. The solid phase was provided by numerically indexed, silicon-based electronic chips, microtransponders (p-Chips) that have previously been used in multiplexed assays. Assay configurations investigated included an ELISA-type immunoassay and a DNA hybridization assay. The surface of p-Chips was derivatized with the silver island film (SIF) and a polymer, and then characterized with AFM and SEM. Silver nanoparticle sizes were in the range of 100 to 200 nm. Four fluorophores were tested for fluorescence enhancement; namely, green fluorescent protein, phycoerythrin, Cy3 and Alexa Fluor 555. We consistently observed significant fluorescence enhancement and sensitivity improvement in the p-Chip-based assays: the sensitivity in the cytokine IL-6 immunoassay was 4.3 pg/ml, which represented a 25-fold increase over the method not involving a SIF; and 50 pM in the hybridization assay, a 38-fold increase. The greatest enhancement was obtained for p-Chip surfaces derivatized first with the polymer and then coated with SIF. In conclusion, we show that the SIF-p-Chip-based platform is a highly sensitive method to quantify low-abundance biomolecules in nucleic acid-based assays and immunoassays.

Indexed as

ElectronicsFluorescent DyesImmunoassayLimit of DetectionMetal NanoparticlesMicroscopy, Atomic ForceSilverFluorescent DyesSilver

Identifiers

PMID20798932
PMCPMC2972226

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.